Last 1,570 GBp
Change Today +4.00 / 0.26%
Volume 1.4M
As of 6:17 AM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher Adam Ph.D.

Director of Commercial Strategy, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 28 board members in 3 different organizations across 4 different industries.

See Board Relationships
57--

Background*

Mr. Christopher Adam, Ph.D., Chris is the Managing Director of GlaxoWellcome KK, Japan. Mr. Adam served as President of French organization at Glaxo, as Regional Director of Japan since 1997 and was also a global board member of GlaxoWellcome. He has over 35 years of board level and operational experience in the pharmaceutical industry, including executive roles in the mergers of Glaxo with Wellcome, and in the acquisition of biotechs such as Affymax. He served as President ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Director
Director

Education*

BS
University College London
MBA
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,570.00 GBp +4.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Sanofi
€700.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.